PDB Short entry for 2GQG HEADER TRANSFERASE 20-APR-06 2GQG TITLE X-RAY CRYSTAL STRUCTURE OF DASATINIB (BMS-354825) BOUND TO ACTIVATED TITLE 2 ABL KINASE DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 229-500; COMPND 5 SYNONYM: P150, C- ABL, ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG COMPND 6 1; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: BACULOGOLD KEYWDS KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.E.KLEI REVDAT 5 18-OCT-17 2GQG 1 REMARK REVDAT 4 13-JUL-11 2GQG 1 VERSN REVDAT 3 20-OCT-09 2GQG 1 HETSYN REVDAT 2 24-FEB-09 2GQG 1 VERSN REVDAT 1 21-NOV-06 2GQG 0 JRNL AUTH J.S.TOKARSKI,J.NEWITT,C.Y.J.CHANG,J.D.CHENG,M.WITTEKIND, JRNL AUTH 2 S.E.KIEFER,K.KISH,F.Y.F.LEE,R.BORZILERRI,L.J.LOMBARDO,D.XIE, JRNL AUTH 3 Y.ZHANG,H.E.KLEI JRNL TITL THE STRUCTURE OF DASATINIB (BMS-354825) BOUND TO ACTIVATED JRNL TITL 2 ABL KINASE DOMAIN ELUCIDATES ITS INHIBITORY ACTIVITY AGAINST JRNL TITL 3 IMATINIB-RESISTANT ABL MUTANTS JRNL REF CANCER RES. V. 66 5790 2006 JRNL REFN ISSN 0008-5472 JRNL PMID 16740718 JRNL DOI 10.1158/0008-5472.CAN-05-4187 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 24996 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 968 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.51 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2952 REMARK 3 BIN R VALUE (WORKING SET) : 0.2210 REMARK 3 BIN FREE R VALUE : 0.2910 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 119 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4505 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.18 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.26 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.530 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.580 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.430 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.420 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PAR REMARK 3 PARAMETER FILE 2 : WATER_REP.PAR REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : LIGAND.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : LIGAND.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GQG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-APR-06. REMARK 100 THE DEPOSITION ID IS D_1000037428. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUL-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.10000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25102 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : 0.12700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 7.60 REMARK 200 R MERGE FOR SHELL (I) : 0.50900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22% W/V PEG3350, 0.2 M MGSO4, 0.1 M REMARK 280 MES BUFFER, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.55000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 52.59600 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 52.59600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 83.32500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 52.59600 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 52.59600 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 27.77500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 52.59600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 52.59600 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 83.32500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 52.59600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 52.59600 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 27.77500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 55.55000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A MONOMER. THERE ARE 2 BIOLOGICAL REMARK 300 UNITS IN THE ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 527 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 568 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 500 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PTR A 393 OH O1P O2P O3P REMARK 470 PTR B 393 P O1P O2P O3P REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 245 -132.20 -85.94 REMARK 500 LYS A 263 -32.44 -39.88 REMARK 500 GLU A 275 -88.68 -53.64 REMARK 500 ASP A 276 -73.22 -66.57 REMARK 500 THR A 277 -69.70 19.06 REMARK 500 THR A 306 -158.04 -106.76 REMARK 500 ARG A 307 -90.57 83.96 REMARK 500 PRO A 309 -165.27 -44.42 REMARK 500 PRO A 310 89.50 5.55 REMARK 500 ASP A 363 33.12 -149.25 REMARK 500 ALA A 380 -162.48 -125.87 REMARK 500 ASP A 381 80.24 50.10 REMARK 500 HIS A 396 -153.51 -85.33 REMARK 500 ALA A 399 163.26 -44.60 REMARK 500 PRO A 402 101.22 -51.41 REMARK 500 TYR A 440 60.22 38.12 REMARK 500 GLU A 499 47.33 -75.74 REMARK 500 LYS B 245 -130.57 -141.28 REMARK 500 LYS B 263 2.85 -57.67 REMARK 500 ASP B 276 -93.81 -76.39 REMARK 500 THR B 277 -103.58 30.67 REMARK 500 PRO B 309 -49.86 -14.69 REMARK 500 ASP B 363 31.64 -147.54 REMARK 500 ASP B 381 75.20 57.81 REMARK 500 ALA B 397 19.98 44.36 REMARK 500 PHE B 497 84.64 -56.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1N1 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1N1 B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1 DBREF 2GQG A 229 500 UNP P00519 ABL1_HUMAN 229 500 DBREF 2GQG B 229 500 UNP P00519 ABL1_HUMAN 229 500 SEQADV 2GQG GLY A 223 UNP P00519 CLONING ARTIFACT SEQADV 2GQG ALA A 224 UNP P00519 CLONING ARTIFACT SEQADV 2GQG MET A 225 UNP P00519 CLONING ARTIFACT SEQADV 2GQG ASP A 226 UNP P00519 CLONING ARTIFACT SEQADV 2GQG PRO A 227 UNP P00519 CLONING ARTIFACT SEQADV 2GQG SER A 228 UNP P00519 CLONING ARTIFACT SEQADV 2GQG PTR A 393 UNP P00519 TYR 393 MODIFIED RESIDUE SEQADV 2GQG GLY B 223 UNP P00519 CLONING ARTIFACT SEQADV 2GQG ALA B 224 UNP P00519 CLONING ARTIFACT SEQADV 2GQG MET B 225 UNP P00519 CLONING ARTIFACT SEQADV 2GQG ASP B 226 UNP P00519 CLONING ARTIFACT SEQADV 2GQG PRO B 227 UNP P00519 CLONING ARTIFACT SEQADV 2GQG SER B 228 UNP P00519 CLONING ARTIFACT SEQADV 2GQG PTR B 393 UNP P00519 TYR 393 MODIFIED RESIDUE SEQRES 1 A 278 GLY ALA MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 A 278 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 A 278 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 A 278 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 A 278 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 A 278 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 A 278 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 A 278 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 A 278 LEU ARG GLU CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL SEQRES 10 A 278 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 A 278 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 A 278 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 A 278 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 A 278 THR PTR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 A 278 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 A 278 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 A 278 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 A 278 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 A 278 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 A 278 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 A 278 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 A 278 MET PHE GLN GLU SER SEQRES 1 B 278 GLY ALA MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 B 278 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 B 278 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 B 278 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 B 278 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 B 278 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 B 278 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 B 278 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 B 278 LEU ARG GLU CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL SEQRES 10 B 278 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 B 278 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 B 278 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 B 278 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 B 278 THR PTR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 B 278 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 B 278 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 B 278 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 B 278 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 B 278 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 B 278 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 B 278 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 B 278 MET PHE GLN GLU SER MODRES 2GQG PTR A 393 TYR O-PHOSPHOTYROSINE MODRES 2GQG PTR B 393 TYR O-PHOSPHOTYROSINE HET PTR A 393 12 HET PTR B 393 12 HET 1N1 A 501 33 HET 1N1 B 502 33 HET GOL B 1 6 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 1N1 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL) HETNAM 2 1N1 PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3- HETNAM 3 1N1 THIAZOLE-5-CARBOXAMIDE HETNAM GOL GLYCEROL HETSYN PTR PHOSPHONOTYROSINE HETSYN 1N1 DASATINIB HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 3 1N1 2(C22 H26 CL N7 O2 S) FORMUL 5 GOL C3 H8 O3 FORMUL 6 HOH *310(H2 O) HELIX 1 1 GLU A 238 THR A 240 5 3 HELIX 2 2 LYS A 263 SER A 265 5 3 HELIX 3 3 GLU A 279 LYS A 291 1 13 HELIX 4 4 LEU A 323 CYS A 330 1 8 HELIX 5 5 ASN A 336 LYS A 357 1 22 HELIX 6 6 ALA A 365 ARG A 367 5 3 HELIX 7 7 GLU A 373 HIS A 375 5 3 HELIX 8 8 PRO A 402 THR A 406 5 5 HELIX 9 9 ALA A 407 TYR A 413 1 7 HELIX 10 10 SER A 417 THR A 434 1 18 HELIX 11 11 ASP A 444 SER A 446 5 3 HELIX 12 12 GLN A 447 LYS A 454 1 8 HELIX 13 13 PRO A 465 TRP A 476 1 12 HELIX 14 14 ASN A 479 ARG A 483 5 5 HELIX 15 15 SER A 485 GLU A 499 1 15 HELIX 16 16 GLU B 238 THR B 240 5 3 HELIX 17 17 LYS B 263 SER B 265 5 3 HELIX 18 18 GLU B 279 GLU B 292 1 14 HELIX 19 19 LEU B 323 GLU B 329 1 7 HELIX 20 20 ASN B 336 LYS B 357 1 22 HELIX 21 21 ALA B 365 ARG B 367 5 3 HELIX 22 22 GLU B 373 HIS B 375 5 3 HELIX 23 23 PRO B 402 THR B 406 5 5 HELIX 24 24 ALA B 407 ASN B 414 1 8 HELIX 25 25 SER B 417 THR B 434 1 18 HELIX 26 26 ASP B 444 SER B 446 5 3 HELIX 27 27 GLN B 447 LYS B 454 1 8 HELIX 28 28 PRO B 465 TRP B 476 1 12 HELIX 29 29 ASN B 479 ARG B 483 5 5 HELIX 30 30 SER B 485 PHE B 497 1 13 SHEET 1 A 5 ILE A 242 LYS A 247 0 SHEET 2 A 5 GLU A 255 TRP A 261 -1 O GLU A 258 N HIS A 246 SHEET 3 A 5 LEU A 266 THR A 272 -1 O VAL A 270 N TYR A 257 SHEET 4 A 5 TYR A 312 GLU A 316 -1 O THR A 315 N ALA A 269 SHEET 5 A 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 B 3 GLY A 321 ASN A 322 0 SHEET 2 B 3 CYS A 369 GLY A 372 -1 O VAL A 371 N GLY A 321 SHEET 3 B 3 LEU A 376 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 C 2 PHE A 359 ILE A 360 0 SHEET 2 C 2 ARG A 386 LEU A 387 -1 O ARG A 386 N ILE A 360 SHEET 1 D 2 PTR A 393 THR A 394 0 SHEET 2 D 2 LYS A 415 PHE A 416 -1 O PHE A 416 N PTR A 393 SHEET 1 E 5 ILE B 242 LYS B 247 0 SHEET 2 E 5 GLU B 255 TRP B 261 -1 O VAL B 260 N THR B 243 SHEET 3 E 5 THR B 267 THR B 272 -1 O THR B 272 N GLU B 255 SHEET 4 E 5 TYR B 312 GLU B 316 -1 O ILE B 313 N LYS B 271 SHEET 5 E 5 LEU B 301 CYS B 305 -1 N LEU B 302 O ILE B 314 SHEET 1 F 3 GLY B 321 ASN B 322 0 SHEET 2 F 3 CYS B 369 VAL B 371 -1 O VAL B 371 N GLY B 321 SHEET 3 F 3 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 G 2 PHE B 359 ILE B 360 0 SHEET 2 G 2 ARG B 386 LEU B 387 -1 O ARG B 386 N ILE B 360 SHEET 1 H 2 LYS B 415 PHE B 416 0 LINK C THR A 392 N PTR A 393 1555 1555 1.32 LINK C PTR A 393 N THR A 394 1555 1555 1.32 LINK C THR B 392 N PTR B 393 1555 1555 1.33 LINK C PTR B 393 N THR B 394 1555 1555 1.33 SITE 1 AC1 17 LEU A 248 ALA A 269 VAL A 270 LYS A 271 SITE 2 AC1 17 GLU A 286 MET A 290 VAL A 299 ILE A 313 SITE 3 AC1 17 THR A 315 GLU A 316 PHE A 317 MET A 318 SITE 4 AC1 17 THR A 319 TYR A 320 GLY A 321 LEU A 370 SITE 5 AC1 17 ALA A 380 SITE 1 AC2 17 LEU B 248 ALA B 269 LYS B 271 GLU B 286 SITE 2 AC2 17 MET B 290 VAL B 299 ILE B 313 THR B 315 SITE 3 AC2 17 GLU B 316 PHE B 317 MET B 318 THR B 319 SITE 4 AC2 17 TYR B 320 GLY B 321 LEU B 370 ALA B 380 SITE 5 AC2 17 HOH B 623 SITE 1 AC3 7 GLY A 442 TYR B 440 PRO B 441 TYR B 456 SITE 2 AC3 7 MET B 458 GLU B 459 HOH B 516 CRYST1 105.192 105.192 111.100 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009506 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009506 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009001 0.00000